BioLargo, Inc. (BLGO)
OTCMKTS
· Delayed Price · Currency is USD
0.190
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST
BioLargo Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 18.49 | 12.23 | 5.88 | 2.53 | 2.43 | 1.86 | Upgrade
|
| Revenue Growth (YoY) | 85.70% | 107.85% | 132.48% | 4.07% | 30.68% | 36.44% | Upgrade
|
| Cost of Revenue | 10.3 | 6.08 | 3.03 | 1.43 | 1.2 | 0.95 | Upgrade
|
| Gross Profit | 8.19 | 6.15 | 2.86 | 1.1 | 1.23 | 0.92 | Upgrade
|
| Selling, General & Admin | 8.98 | 8.06 | 6.73 | 6.17 | 7.47 | 6.14 | Upgrade
|
| Research & Development | 2.53 | 2.28 | 1.32 | 1.37 | 1.34 | 1.47 | Upgrade
|
| Other Operating Expenses | -0 | 0.01 | -0.06 | -0.02 | -0.11 | -0.06 | Upgrade
|
| Operating Expenses | 11.52 | 10.35 | 7.99 | 7.52 | 8.7 | 7.55 | Upgrade
|
| Operating Income | -3.33 | -4.2 | -5.13 | -6.42 | -7.47 | -6.63 | Upgrade
|
| Interest Expense | -0.03 | -0.09 | -0.05 | -0.23 | -1.92 | -4 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.02 | 0.04 | 0.07 | 0.06 | 0.14 | 0.22 | Upgrade
|
| EBT Excluding Unusual Items | -3.34 | -4.25 | -5.11 | -6.6 | -9.26 | -10.41 | Upgrade
|
| Asset Writedown | -0.39 | -0.39 | -0.2 | -0.34 | - | - | Upgrade
|
| Other Unusual Items | 0.1 | - | 0.17 | 0.04 | -0.44 | -1.03 | Upgrade
|
| Pretax Income | -3.64 | -4.65 | -5.13 | -6.89 | -9.7 | -11.44 | Upgrade
|
| Earnings From Continuing Operations | -3.64 | -4.65 | -5.13 | -6.89 | -9.7 | -11.44 | Upgrade
|
| Minority Interest in Earnings | 1.52 | 1.14 | 0.66 | -0.19 | 1.27 | 0.75 | Upgrade
|
| Net Income | -2.12 | -3.5 | -4.47 | -7.08 | -8.43 | -10.69 | Upgrade
|
| Net Income to Common | -2.12 | -3.5 | -4.47 | -7.08 | -8.43 | -10.69 | Upgrade
|
| Shares Outstanding (Basic) | 295 | 286 | 268 | 247 | 196 | 152 | Upgrade
|
| Shares Outstanding (Diluted) | 295 | 286 | 268 | 247 | 196 | 152 | Upgrade
|
| Shares Change (YoY) | 4.60% | 6.58% | 8.53% | 26.13% | 28.87% | 24.66% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 | -0.07 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 | -0.07 | Upgrade
|
| Free Cash Flow | -2.7 | -2.84 | -3.03 | -3.96 | -4.18 | -4.46 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | Upgrade
|
| Gross Margin | 44.29% | 50.32% | 48.56% | 43.58% | 50.49% | 49.22% | Upgrade
|
| Operating Margin | -17.99% | -34.33% | -87.19% | -253.50% | -307.24% | -356.42% | Upgrade
|
| Profit Margin | -11.45% | -28.65% | -76.02% | -279.73% | -346.71% | -574.42% | Upgrade
|
| Free Cash Flow Margin | -14.59% | -23.25% | -51.55% | -156.38% | -171.75% | -239.49% | Upgrade
|
| EBITDA | -3.2 | -4.1 | -5.09 | -6.4 | -7.41 | -6.57 | Upgrade
|
| EBITDA Margin | -17.32% | -33.49% | -86.42% | -252.71% | - | - | Upgrade
|
| D&A For EBITDA | 0.12 | 0.1 | 0.05 | 0.02 | 0.06 | 0.07 | Upgrade
|
| EBIT | -3.33 | -4.2 | -5.13 | -6.42 | -7.47 | -6.63 | Upgrade
|
| EBIT Margin | -17.99% | -34.33% | -87.19% | -253.50% | - | - | Upgrade
|
| Revenue as Reported | 18.49 | 12.23 | 5.88 | 2.53 | 2.43 | 1.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.